Reno, NV – July 21, 2017 – CIBL, Inc. (“CIBL” or the “Company”; OTC Pink ®: CIBY) announces that at June 30, 2017, CIBL held $22.0 million in liquid assets or $1,322 per share, based on the 16,635 shares outstanding at that date; 166,556 shares of ICTC valued at $5.0 million pre-tax, or $300 per CIBL share; and 10,000 shares of Solix Inc., a private outsourcing firm that provides, among other services, billing and collection for the telecommunications industry.
ICTC Group Inc. – The company owns 166,556 common shares of ICTC Group, Inc. (“ICTC”; OTC Pink ®: ICTG), or 44% of the shares outstanding, and has voting control (56% of total votes) through a voting rights agreement with our Chairman. CIBL’s total investment in its ICTC shares is $3.8 million. Based on the last trading price of these shares, the total pre-tax marked to market value is $5.0 million, or $300 per share of CIBL outstanding. Information on ICTC can be obtained on its website, www.ictcgroup.net.
Share Repurchases – During the six months ended June 30, 2017, the Company acquired 199 of its shares at an average price of $1,333 per share. We now have 16,635 shares outstanding. Since its spin-off from LICT Corporation in 2007, CIBL has repurchased 8,480 of its shares for a total of $9.7 million, or an average price of $1,139 per share.
* * * *
This release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and it should be recognized that such information is based upon assumptions, projections and forecasts, including without limitation business conditions and financial markets, and the cautionary statements set forth in documents filed by CIBL on its website, www.ciblinc.com. Thus, such information is subject to uncertainties, risks and inaccuracies, which could be material, and there can be no assurance that such information is accurate.
CIBL is a holding company with interests in telecommunications operations. CIBL is listed on OTC Pink® under the symbol CIBY and information can be obtained on our website: www.ciblinc.com.
Contact: Robert E. Dolan